Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2001
07/18/2001EP1115380A2 Micronised pharmaceutical compositions
07/18/2001EP1115378A1 Oral mucoadhesive compositions containing gastrointestinal actives
07/18/2001EP1115375A1 Use of at least a10-hydroxy-2- decenoic acid derivative in a composition for promoting skin scaling
07/18/2001EP1115373A1 Oral composition with an improved teeth whitening effect
07/18/2001EP1115372A2 Fast dissolving orally consumable films
07/18/2001EP1115371A1 Oral care compositions
07/18/2001EP1115295A2 Method of protecting heat- or oxygen-labile compounds to preserve activity and bioavailability
07/18/2001EP1115289A2 Environmentally benign crop protection agents
07/18/2001EP1115286A1 Methods for treating or preventing viral infections and associated diseases
07/18/2001EP1115285A1 Safe and effective biofilm inhibitory compounds and health-related uses thereof
07/18/2001EP1115284A1 Antifouling agents
07/18/2001EP1034171B1 Pseudopolymorphic forms of 2-[2-[4-[bis(4-fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride
07/18/2001EP1033369A4 5H-PYRANO [2,3-d:6,5-d']DIPYRIMIDINE DERIVATIVES HAVING AN ANTIBACTERIAL, ANTIVIRAL AND IMMUNO-MODULATING ACTIVITY
07/18/2001EP0928196A4 Beta-glucan products and extraction processes from cereals
07/18/2001EP0850221B1 Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists
07/18/2001EP0846170B1 Modified protein kinase a-specific oligonucleotides and methods of their use
07/18/2001EP0824539B1 Dialkyltiacumicin compounds
07/18/2001EP0823903B1 Heterocyclic diaryl compounds, pharmaceutical and cosmetic compositions containing same, and uses thereof
07/18/2001EP0793667B1 Trinuclear cationic platinum complexes having antitumour activity and pharmaceutical compositions containing them
07/18/2001EP0758235B1 Polymer coated tablet comprising amoxycillin and clavulanate
07/18/2001EP0713870B1 Novel fused indan derivative and pharmaceutically acceptable salt thereof
07/18/2001EP0700288B1 Inhibition of hair growth
07/18/2001EP0674521B1 METHOD OF TREATMENT OF CHRONIC PROSTATITIS WITH 17$g(b)-N-TERTBUTYLCARBAMOYL-4-AZA-5$g(a)-ANDROST-1-EN-3-ONE
07/18/2001EP0636025B1 Compounds useful for treating allergic or inflammatory diseases
07/18/2001EP0607122B1 Veterinary treatment
07/18/2001EP0440626B1 Synthetic gtf chromium material and process therefor
07/18/2001CN1304447A Treatment of parasitic diseases by inhibition of cysteine proteases of papain superfamily
07/18/2001CN1304413A Form VI5,6-dichloro-2-(isopropylamino)-1-(&beta-L-ribofuranosyl)-1H-benzimidazole
07/18/2001CN1304412A Process for preparing crystalline salts of amoxycillin
07/18/2001CN1304411A Acetylcholine enhancers
07/18/2001CN1304410A Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
07/18/2001CN1304409A Indol-3-Yl-cyclohexyl amide derivatives for treatment of depression (5-HT1 receptor antagonists)
07/18/2001CN1304408A N-benzodioxanylmethyl-piperidyl-methylamine compounds having effinity for 5-HT receptors
07/18/2001CN1304407A N-aryloxyethyl-indoly-alkylamines for treatment of depression
07/18/2001CN1304406A Heterocyclic glycyl beta-alanine derivatives as vitronectin antagonists
07/18/2001CN1304404A Cyanoiminoquinoxaline derivatives
07/18/2001CN1304403A N-aryloxyethyl-indoly-alkylamines for treatment of depression (5-HT1A receptor active agents)
07/18/2001CN1304402A Sulfonamide derivatives
07/18/2001CN1304401A Calcilytic compounds
07/18/2001CN1304400A Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
07/18/2001CN1304397A Hyperforin derivatives, the use thereof and formulations containing them
07/18/2001CN1304322A Stabilization of compositions containing ACE inhibitors using magnesium oxide
07/18/2001CN1304321A Composition for transdermal administration of non-steroidal anti-inflammatory drugs
07/18/2001CN1304320A Drug composition containing PGD antagonists for curing inthing
07/18/2001CN1304319A Cervical ripening agent and cervical ripening method
07/18/2001CN1304318A Prostaglandin EP4 receptor agonist and treatment method
07/18/2001CN1304314A Extracts of i(hypericum perforatum) and formulations containing them
07/18/2001CN1304311A Bridged indenopyrrolocarbazoles
07/18/2001CN1304310A Semi-solid aqueous preparations for oral applications of toltrazuril sulphone
07/18/2001CN1304309A Semi-synthetic ecteinascidins
07/18/2001CN1304308A Aqueous process for manufacturing paroxetine solid dispersions
07/18/2001CN1304307A 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective NMDA receptor antagonists
07/18/2001CN1304306A Method for inhibiting MRP1
07/18/2001CN1304290A Pulmonary and nasal delivery of Raloxifene
07/18/2001CN1303859A Carbazole derivatives their preparing process and pharmaceutical composition containing them
07/18/2001CN1303858A Tetrahydroxydiphenylethylene glycosides compounds for preventing and curing angiocardiopathy and cerebrovascular diseases
07/18/2001CN1303712A Mixed medicine for resisting cancer
07/18/2001CN1303682A Preparation method of medicine for curing surgical diseases of traditional Chinese medicine
07/18/2001CN1303675A Point-injection for curing asthma and trachitis
07/18/2001CN1303674A Alprazolam nasal spray
07/18/2001CN1303673A Application of sophocarpine in preparation of medicine for curing coxsackievirus B myocarditis and its preparation method
07/18/2001CN1303672A Application of cinnamate in preparation of medicine for curing diabetes
07/18/2001CN1303671A Application of cinnamic acid in preparation of medicine for curing diabetes
07/18/2001CN1303670A Product with powder stable vitamine and/or carotenoid and its producing process
07/18/2001CN1068602C Pyrimidine nucleoside derivatives
07/18/2001CN1068598C Resolution of 1-azabicyclo [2.2.2] octan-3-amine, 2-(diphenylmethyl)-N-[[2-methoxy-5-(1-methylethyl) phenyl]methyl]
07/18/2001CN1068592C Imidazole derivatives having affinity for alpha 2 receptors activity
07/18/2001CN1068591C 1,3-dihydro-1-(phenylalkyl)-2H-imdiazol-2-one derivatives having PDEIV and cytokine activity
07/18/2001CN1068590C 1,3-dihydro-1-(phonylalkenyl)-2H-imidazol-2-one derivatives having PDEIV and cytokine inhibiting activity
07/18/2001CN1068588C 1H-indole-3-acetamide splA2 inhibitors
07/18/2001CN1068587C Ortho-substituted benzoic acid derivatives
07/18/2001CN1068586C Crystalline polymorphic form of (S.S.S)-N-(1-[2-carboxy-3-(N2-mesyllysylamino)propyl]-1-cyclopenlylcarbonyl) throsine
07/18/2001CN1068583C N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
07/18/2001CN1068519C Medicinal composition for curing ulcer of upper digestive tract and effectively inhibiting recurrance thereof
07/18/2001CN1068518C Wettable powder of niclosamide salt
07/18/2001CN1068517C Use of 2(3) tertiary butyl-4-hydroxy-anisole in preparation of drug for preventing and curing tissue organ traumatic disease
07/18/2001CN1068516C Dual alcohol injection
07/18/2001CA2332169A1 Treatments for obesity and methods for identifiying compounds useful for treating obesity
07/18/2001CA2296997A1 Treatment of congestive heart failure
07/17/2001USRE37285 Polyoxypropylene/polyoxyethylene copolmers with improved biological activity
07/17/2001US6262316 Administering a xanthophylles
07/17/2001US6262302 N-(aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
07/17/2001US6262282 17β-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis
07/17/2001US6262277 Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
07/17/2001US6262271 ISO-CBI and ISO-CI analogs of CC-1065 and the duocarmycins
07/17/2001US6262267 Has gonadotropin-releasing hormone antagonizing activity; useful for preventing or treating sex hormone-dependent diseases, e,g., sex hormone-dependent cancers e.g., prostatic cancer, uterine cancer, breast cancer, pituitary tumor
07/17/2001US6262260 Process for the preparation of midazolam
07/17/2001US6262257 Selective ion- and neutral molecule-binding agents forming supramolecular ensembles, and ion- and neutral molecule-separation agents
07/17/2001US6262253 Vitamin B12 conjugates with gcsf, analogues thereof and pharmaceutical compositions
07/17/2001US6262246 DNA encoding mammalian neuropeptides FF (NPFF) receptors and uses thereof
07/17/2001US6262227 Process for producing a cationic polymer
07/17/2001US6262216 Used to form a functionalized coating on substrate; array of nucleic acids may be covalently attached to substrate to make high density arrays to nucleic acids immobilized on substrate which may be used in high volume nucleic acid hybridization
07/17/2001US6262172 Method for preparing a carbonized resin DNA immunoadsorbent
07/17/2001US6262126 Semi-fluorinated alkanes and their use
07/17/2001US6262125 Has antineoplastic, antidirrheal, antiperistaltic, gastrointestinal antispasmodic, antiviral, antiretroviral, antipsoriasis and insecticidal activities
07/17/2001US6262123 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them
07/17/2001US6262122 Enantiomers of 4-[[(cyanoimino) [(1,2,2-trimethylpropyl)amino]methyl]amino]benzonitrile
07/17/2001US6262121 Oily patches for external use containing diclofenac sodium
07/17/2001US6262120 GABA and L-glutamic acid analogs for antiseizure treatment
07/17/2001US6262119 Methods of treating immunopathologies using polyunsaturated fatty acids